HORMONE SENSITIVE/ HORMONE RESISTANT PROSTATE CANCER Daniel H Shevrin, MD Hematology/Oncology Northshore University HealthSystem.
Adaptive designs as enabler for personalized medicine Michael Krams M.D. Janssen Pharmaceuticals, Titusville, NJ [email protected] Thanks to Donald A.
Preoperative fluorouracil (FU)-based chemoradiation +/- weekly oxaliplatin in locally advanced rectal cancer. Pathologic response analysis of the STAR.
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC Alexa B. Turke, Kreshnik Zejnullahu, Yi-Long Wu, Youngchul Song, Dora Dias-Santagata,
Immunology at the University of Virginia. About me….. PhD Biochemistry University of Illinois Postdoc Immunology Harvard University At UVA since 1980.
Dr ... Journal
Abstracts 4005-8 Jordan Berlin, MD Ingram Professor of Clinical Research Co-Director, GI Oncology Program Vanderbilt-Ingram Cancer Center.
Systemic Therapy of Melanoma: The Dawn of A New Era
FDA Review : Cisplatin / Epinephrine Gel (CEG) in the Treatment of Head and Neck Cancer.
Abstracts 4005-8
Howard I. Scher, MD Chief, Genitourinary Oncology Service Memorial Sloan Kettering Cancer Center
Radiotherapy in Renal Cell Carcinoma
